Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
about
Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknownFatal ruxolitinib-related JC virus meningitis.Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.New and emerging therapies for acute and chronic graft versus host disease.Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification.ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphat
P2860
Q33875468-0651A17B-6768-4693-9477-6510BCBD9A58Q40044044-122CD053-8974-4CAF-8443-C14BE6B48978Q40100891-14DD221E-1E90-4096-9C42-008F0BC721B8Q45325710-C7B57AF7-C0E7-46CF-8B79-EAB35BB18FCEQ47798734-17356026-9708-4BB3-B38C-99C21EA62256Q49238507-6A33A017-77BD-477D-A525-B37D7DFE5533Q49906338-15396119-CDC1-4CFC-A085-5CA3B3AE9AB5Q49950638-23AEB5BD-0F95-44C1-BB7E-142FAB003CB6Q50086043-17A88377-4077-40AC-B83D-A1B2146A886B
P2860
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@ast
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@en
type
label
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@ast
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@en
prefLabel
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@ast
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@en
P50
P1433
P1476
Natalizumab-associated PML: Ch ...... risk, and risk stratification.
@en
P2093
Gary Cutter
Nico Melzer
P304
P356
10.1212/WNL.0000000000003739
P407
P577
2017-02-22T00:00:00Z